Benvenuti nel Sito del Settore Healthcare di Siemens
Le informazioni contenute in questo sito sono destinate in via esclusiva agli Operatori Sanitari in conformità all’art. 21 del D.Lgs. 24 febbraio 1997, n. 46 s.m.i e alle Linee Guida del Ministero della Salute del 17 febbraio 2010. Se intendete accedere alle informazioni, cliccando sul pulsante “Operatore sanitario” dichiarate e confermate sotto la vostra esclusiva responsabilità di essere un Operatore Sanitario
The ACUSON X300™ ultrasound system, premium edition (PE) is a compact, portable imaging solution that delivers exceptional clinical performance across a wide variety of applications. This comprehensive, fully featured system incorporates high-end image optimization techniques and enhanced workflow features to meet the challenges of the most demanding care environments.
The ACUSON X300 PE platform addresses a broad range of solutions including - general imaging, shared service, OB/GYN, comprehensive cardiology, urology, endocrinology, emergency medicine and many other specialized applications. Below is a list of advanced technologies and options available:
The Plus Option is a specialized hardware option which doubles the system channel count to expand performance and increase dynamic range, while improving image quality and increasing diagnostic confidence.
Superior clinical performance. The ACUSON X300 PE is a robust system created to handle a wide variety of clinical applications with unmatched versatility and accessibility to the latest Siemens pioneering technologies.
Achieve unparalleled efficiency. Designed for your comfort and flexibility, the ACUSON X300 PE and its ErgoDynamic™ imaging system design make this system easy to maneuver and easy to use in any care environment. It provides features and tools that move you quickly through your exams from beginning to end.
* This feature should be utilized according to the ASE Consensus Statement "Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, Endorsed by the Society for Vascular Medicine.”
**At the time of publication, the U.S. Food and Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check current regulations for the country in which you are using this system for contrast agent clearance.